Tag:
interferon
Latest Headlines
Latest Headlines
CDC delivers gift to hep C drugmakers
The recommendation by the CDC that the 70 million U.S. baby boomers all be tested for hepatitis C is a big gift for the newest hep C treatments.
FDA hits brakes on Novartis' hep C program after death
U.S. regulators have put a hold on Novartis' clinical trial for experimental hepatitis C drug alisporivir after cases of pancreatitis were reported in the trial and one patient in the study died.
Analysts pounce on positive Phase II data on hep C combo
Jefferies analyst Thomas Wei posted some positive results from an all-oral combo of Gilead's 7977 and Bristol-Myers Squibb's daclatasvir (BMS-52).
Abbott wows the crowd with promising Phase II hep C data
You can count Abbott as a key player in the hot hepatitis C drug development race.
Okairos launches pioneering mid-stage study of promising hep C vaccine
As far as most biotech investors are concerned, the most exciting work being done in the hepatitis C field involves next-gen treatments that can potentially quell the virus without the need for the troublesome interferon in the combo.
Vertex outlines its survival plan for next-gen hep C combo
At the beginning of 2011, Vertex ( $VRTX ) was basking in the limelight of blockbuster success. Its hepatitis C drug was headed for approval, offering a game-changing approach to the disease, and was
